A Description of COVID-19-Directed Therapy in Children Admitted to US Intensive Care Units 2020
| Autor: | Jennifer E, Schuster, Natasha B, Halasa, Mari, Nakamura, Emily R, Levy, Julie C, Fitzgerald, Cameron C, Young, Margaret M, Newhams, Florence, Bourgeois, Mary A, Staat, Charlotte V, Hobbs, Heda, Dapul, Leora R, Feldstein, Ashley M, Jackson, Elizabeth H, Mack, Tracie C, Walker, Aline B, Maddux, Philip C, Spinella, Laura L, Loftis, Michele, Kong, Courtney M, Rowan, Melania M, Bembea, Gwenn E, McLaughlin, Mark W, Hall, Christopher J, Babbitt, Mia, Maamari, Matt S, Zinter, Natalie Z, Cvijanovich, Kelly N, Michelson, Shira J, Gertz, Christopher L, Carroll, Neal J, Thomas, John S, Giuliano, Aalok R, Singh, Saul R, Hymes, Adam J, Schwarz, John K, McGuire, Ryan A, Nofziger, Heidi R, Flori, Katharine N, Clouser, Kari, Wellnitz, Melissa L, Cullimore, Janet R, Hume, Manish, Patel, Adrienne G, Randolph |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
treatment
Critical Illness COVID-19 remdesivir General Medicine Hospitals Pediatric intensive care unit United States COVID-19 Drug Treatment Hospitalization Intensive Care Units Infectious Diseases AcademicSubjects/MED00290 pediatric Pediatrics Perinatology and Child Health Humans Original Article Child AcademicSubjects/MED00670 |
| Zdroj: | Journal of the Pediatric Infectious Diseases Society |
| ISSN: | 2048-7207 |
| Popis: | Background It is unclear how acute coronavirus disease 2019 (COVID-19)-directed therapies are used in children with life-threatening COVID-19 in US hospitals. We described characteristics of children hospitalized in the intensive care unit or step-down unit (ICU/SDU) who received COVID-19-directed therapies and the specific therapies administered. Methods Between March 15, 2020 and December 27, 2020, children No therapies for acute coronavirus disease 2019 (COVID-19) have been tested in children to establish effectiveness. Despite this, across 48 hospitals, 235/424 children (55%) admitted to the intensive care or step-down unit with COVID-19 received directed therapies. Systemic steroids and remdesivir were most commonly administered, with use rising from March 2020 to December 2020. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|